Retatrutide is a triple agonist researched for metabolic and weight-management applications in preclinical and research settings.
Retatrutide is an investigational peptide that acts on three incretin pathways (GLP-1, GIP and glucagon receptors). As a research compound, it is supplied as a lyophilized powder with high purity and full documentation for laboratory and animal studies. PepNova manufactures Retatrutide in-house with verified COA and HPLC on every batch.
Retatrutide is studied as a triple receptor agonist in metabolic and obesity-related preclinical research. It is not approved for human therapeutic use.
Every batch ships with a Certificate of Analysis (COA), HPLC chromatogram and MSDS. Third-party testing is available on request.
Typical purity is >=99% by HPLC. Exact values are stated on each batch's COA.
Explore more research peptides from PepNova.
Send your target quantity and specification — we'll return a tailored quote and COA sample.
Request a Quote